0001550020 false 0001550020 2022-07-22 2022-07-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(D) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 22, 2022

 

eWELLNESS HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

 

Nevada   000-55203   90-1073143

(State or other jurisdiction

of Incorporation)

  

(Commission

File Number

  

(IRS Employer

identification Number

 

eWellness Healthcare Corporation

1126 S Federal Highway #464

Ft. Lauderdale FL 33316

(Address of principal executive offices)

 

Registrant’s Telephone Number, including area code: (855) 470-1700

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On July 22. 2022 at 10:00 a.m., the following directors and officers of eWellness Healthcare Corporation (the Company) resigned any and all positions with the Company, including: Douglas MacLellan, Chairman and CEO, David Markowski, CFO and Director, and Doug Cole, Director. Over the past year the Company has continued to operate through advances provided by certain shareholders. Due to the current economic conditions, these shareholders are unwilling to continue to fund the Company, leaving the Company with no financial resources to continue paying bills as they come due, including professional fees related to public filings under the Securities Exchange Act of 1934, paying for administrative fees and expenses and/or working to complete various merger transactions. None of these directors or officers indicated any disagreements with the Company on any matter relating to its operations, policies or practices. Their respective letters of resignation are attached as Exhibits to this Form 8-K.

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: July 25, 2022 By: /s/ Douglas MacLellan
  Name: Douglas MacLellan
  Title: Chairman of the Board and CEO

 

 

eWellness Healthcare (CE) (USOTC:EWLL)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more eWellness Healthcare (CE) Charts.
eWellness Healthcare (CE) (USOTC:EWLL)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more eWellness Healthcare (CE) Charts.